SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026023
Filing Date
2022-11-04
Accepted
2022-11-04 16:01:44
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pirs20220630_10q.htm   iXBRL 10-Q 1300112
2 EXHIBIT 10.1 ex_440605.htm EX-10.1 101490
3 EXHIBIT 10.2 ex_440606.htm EX-10.2 29107
4 EXHIBIT 31.1 ex_393845.htm EX-31.1 8526
5 EXHIBIT 31.2 ex_393846.htm EX-31.2 9241
6 EXHIBIT 32.1 ex_393847.htm EX-32.1 4019
7 EXHIBIT 32.2 ex_393848.htm EX-32.2 3999
  Complete submission text file 0001437749-22-026023.txt   5868895

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pirs-20220930.xsd EX-101.SCH 51050
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20220930_cal.xml EX-101.CAL 36463
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20220930_def.xml EX-101.DEF 322960
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20220930_lab.xml EX-101.LAB 302496
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20220930_pre.xml EX-101.PRE 344605
53 EXTRACTED XBRL INSTANCE DOCUMENT pirs20220630_10q_htm.xml XML 890425
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 221362247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)